Exclusive: Trump administration banned chosen names at FDA, CDC, NIH under new gender policy [View all]
Source: USA Today
April 30, 2025, 4:04 p.m. ET
Employees of the Food and Drug Administration, the National Institutes of Health, and the Centers for Disease Control and Prevention are being told to use their legal names in official systems, a move the agencies say is in response to President Donald Trump's executive order that reversed protections for transgender people.
The policies affect transgender employees who use a name that aligns with their gender identity rather than the sex they were assigned at birth. But the policies can also affect married women who choose to go by their maiden names at work, and people who go by middle names, initials, or shorten their first names, for example, from James to Jim.
The FDA, CDC, and NIH policies go beyond a January directive from the Office of Personnel Management that ordered agencies to purge contracts and content related to gender identity and turn off features on email platforms that prompt users for their pronouns. Both agencies are part of the Department of Health and Human Services.
Media representatives for the White House, the HHS, NIH, and the CDC did not respond to USA TODAYs request for comment. The FDA website refers media inquiries to HHS.
Read more: https://www.usatoday.com/story/news/politics/2025/04/30/fda-nih-hhs-name-gender-policy-trump/83254129007/